Spyre Therapeutics, Inc.

OSAIC HOLDINGS, INC. SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/21/2023

Shares

5,000

Value ($000)

2

Weight

0.0%

2020 Q1 - 2023 Q2 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/21/2023	2	0.0%	5,000	6/30/2023
2022 Q2	8/10/2022	0	0.0%	470	6/30/2022
2020 Q3	11/12/2020	6	0.0%	785	9/30/2020
2020 Q2	8/14/2020	7	0.0%	785	6/30/2020
2020 Q1	5/18/2020	4	0.0%	785	3/31/2020